Feed MEM.AX
ME
Memphasys Limited
MEM.AX · ASX
$0.01 +0.00% (+$0.00)
1M -25.00%
Market Cap $18.5M
P/E Ratio -
Div. Yield -
ROE 79.40%
Valuation
30 /100
Expensive P/S 35.15x
P/B 3.45x
P/E N/A
Growth
78 /100
Growing Rev. growth 168.74%
Book val. growth 11.12%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 81.81%
FCF margin 457.33%
Net margin 937.89%
Quality
1 /100
Poor ROIC 24.48%
Asset turnover 0.05x
ROE 79.40%
Debt
24 /100
High Debt/Equity 0.95x
Int. coverage -5.52x
Current ratio 0.25x
Stability
30 /100
Unstable Beta 0.47x
Profitable years 0
Rev. volatility 413.19%
Întreabă StockBot despre MEM.AX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
R. John Aitken
Employees
24
Headquarters
Homebush